{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T20:47:46Z","timestamp":1789678066377,"version":"4.0.1"},"reference-count":138,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T00:00:00Z","timestamp":1583971200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T00:00:00Z","timestamp":1583971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Even though fertility is reduced, conception and delivery are possible in all stages of CKD. While successful planned pregnancies are increasing, an unwanted pregnancy may have long-lasting deleterious effects, hence the importance of birth control, an issue often disregarded in clinical practice. The evidence summarized in this position statement is mainly derived from the overall population, or other patient categories, in the lack of guidelines specifically addressed to CKD. Oestroprogestagents can be used in early, non-proteinuric CKD, excluding SLE and immunologic disorders, at high risk of thromboembolism and hypertension. Conversely, progestin only is generally safe and its main side effect is intramestrual spotting. Non-medicated intrauterine devices are a good alternative; their use needs to be carefully evaluated in patients at a high risk of pelvic infection, even though the degree of risk remains controversial. Barrier methods, relatively efficacious when correctly used, have few risks, and condoms are the only contraceptives that protect against sexually transmitted diseases. Surgical sterilization is rarely used also because of the risks surgery involves; it is not definitely contraindicated, and may be considered in selected cases. Emergency contraception with high-dose progestins or intrauterine devices is not contraindicated but should be avoided whenever possible, even if far preferable to abortion. Surgical abortion is invasive, but experience with medical abortion in CKD is still limited, especially in the late stages of the disease. In summary, personalized contraception is feasible, safe and should be offered to all CKD women of childbearing age who do not want to get pregnant.<\/jats:p>","DOI":"10.1007\/s40620-020-00717-0","type":"journal-article","created":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T10:04:01Z","timestamp":1584007441000},"page":"1343-1359","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Contraception in chronic kidney disease: a best practice position statement by the Kidney and Pregnancy Group of the Italian Society of Nephrology"],"prefix":"10.1093","volume":"33","author":[{"given":"Rossella","family":"Attini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranca","family":"Cabiddu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetta","family":"Montersino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Gammaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Gernone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Moroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Santoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donatella","family":"Spotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Masturzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella Bianca","family":"Gazzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Menato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Donvito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Paoletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgina Barbara","family":"Piccoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,3,12]]},"reference":[{"issue":"7637","key":"717_CR1","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1136\/bmj.39406.652986.BE","volume":"336","author":"D Williams","year":"2008","unstructured":"Williams D, Davison J (2008) Chronic kidney disease in pregnancy. BMJ 336(7637):211\u2013215","journal-title":"BMJ"},{"issue":"2","key":"717_CR2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ekir.2018.01.001","volume":"3","author":"GB Piccoli","year":"2018","unstructured":"Piccoli GB, Alrukhaimi M, Liu ZH, Zakharova E, Levin A, World Kidney Day Steering Committee (2018) Women and kidney diseases: questions unanswered and answers unquestioned. Kidney Int Rep 3(2):225\u2013235","journal-title":"Kidney Int Rep"},{"issue":"5","key":"717_CR3","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.semnephrol.2015.08.010","volume":"35","author":"AG Kattah","year":"2015","unstructured":"Kattah AG, Garovic VD (2015) Pregnancy and lupus nephritis. Semin Nephrol 35(5):487\u2013499","journal-title":"Semin Nephrol"},{"key":"717_CR4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejim.2016.04.005","volume":"32","author":"G Moroni","year":"2016","unstructured":"Moroni G, Ponticelli C (2016) Pregnancy in women with systemic lupus erythematosus (SLE). Eur J Intern Med. 32:7\u201312","journal-title":"Eur J Intern Med."},{"issue":"Suppl 3","key":"717_CR5","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/ndt\/gfs302","volume":"27","author":"GB Piccoli","year":"2012","unstructured":"Piccoli GB, Fassio F, Attini R, Parisi S, Biolcati M, Ferraresi M, Pagano A, Daidola G, Deagostini MC, Gaglioti P, Todros T (2012) Pregnancy in CKD: whom should we follow and why? Nephrol Dial Transplant. 27(Suppl 3):111\u2013118","journal-title":"Nephrol Dial Transplant."},{"issue":"4","key":"717_CR6","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1053\/j.ajkd.2016.07.034","volume":"69","author":"AG Kattah","year":"2017","unstructured":"Kattah AG, Scantlebury DC, Agarwal S, Mielke MM, Rocca WA, Weaver AL, Vaughan LE, Miller VM, Weissgerber TL, White W, Garovic VD (2017) Preeclampsia and ESRD: the role of shared risk factors. Am J Kidney Dis 69(4):498\u2013505","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"717_CR7","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s40620-019-00629-8","volume":"32","author":"Z Filali Khattabi","year":"2019","unstructured":"Filali Khattabi Z, Biolcati M, Fois A, Chatrenet A, Laroche D, Attini R, Cheve MT, Piccoli GB (2019) Chronic kidney disease in preeclamptic patients: not found unless searched for-Is a nephrology evaluation useful after an episode of preeclampsia? J Nephrol. 32(6):977\u2013987","journal-title":"J Nephrol."},{"issue":"6","key":"717_CR8","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1053\/j.ajkd.2015.08.023","volume":"66","author":"A Tong","year":"2015","unstructured":"Tong A, Brown MA, Winkelmayer WC, Craig JC, Jesudason S (2015) Perspectives on pregnancy in women with CKD: a semistructured interview study. Am J Kidney Dis 66(6):951\u2013961","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"717_CR9","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1093\/ndt\/gfu378","volume":"30","author":"A Tong","year":"2015","unstructured":"Tong A, Jesudason S, Craig JC, Winkelmayer WC (2015) Perspectives on pregnancy in women with chronic kidney disease: systematic review of qualitative studies. Nephrol Dial Transplant 30(4):652\u2013661","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"717_CR10","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1007\/s11255-017-1577-z","volume":"49","author":"GF van Ek","year":"2017","unstructured":"van Ek GF, Krouwel EM, Nicolai MPJ, Den Oudsten BL, Den Ouden MEM, Dieben SWM, Putter H, Pelger RCM, Elzevier HW (2017) What is the role of nephrologists and nurses of the dialysis department in providing fertility care to CKD patients? A questionnaire study among care providers. Int Urol Nephrol 49(7):1273\u20131285","journal-title":"Int Urol Nephrol"},{"issue":"12","key":"717_CR11","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1111\/jsm.13062","volume":"12","author":"GF van Ek","year":"2015","unstructured":"van Ek GF, Krouwel EM, Nicolai MP, Bouwsma H, Ringers J, Putter H, Pelger RC, Elzevier HW (2015) Discussing sexual dysfunction with chronic kidney disease patients: practice patterns in the office of the nephrologist. J Sex Med. 12(12):2350\u20132363","journal-title":"J Sex Med."},{"issue":"2","key":"717_CR12","doi-asserted-by":"publisher","first-page":"E176","DOI":"10.3390\/jcm8020176","volume":"8","author":"EM Hendren","year":"2019","unstructured":"Hendren EM, Reynolds ML, Mariani LH, Zee J, O\u2019Shaughnessy MM, Oliverio AL, Moore NW, Hill-Callahan P, Rizk DV, Almanni S, Twombley KE, Herreshoff E, Nester CM, Hladunewich MA (2019) Confidence in women\u2019s health: a cross border survey of adult nephrologists. J Clin Med. 8(2):E176. https:\/\/doi.org\/10.3390\/jcm8020176","journal-title":"J Clin Med."},{"issue":"1","key":"717_CR13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1755-6686.2007.tb00031.x","volume":"33","author":"M Calic","year":"2007","unstructured":"Calic M, Grego K, Kersnic B, Jovanovic E, Svetlin M, Kandus A (2007) Education of transplanted women for prevention of unplanned pregnancy following kidney transplantation. J Ren Care 33(1):17\u201319","journal-title":"J Ren Care"},{"key":"717_CR14","doi-asserted-by":"crossref","first-page":"e13631","DOI":"10.1111\/ctr.13631","volume":"7","author":"PK Phillips","year":"2019","unstructured":"Phillips PK, Saha S, Foley DP, Iruretagoyena JI, Said A (2019) Deficiencies in reproductive health counseling in liver transplant recipients. Clin Transplant 7:e13631","journal-title":"Clin Transplant"},{"issue":"3","key":"717_CR15","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/tri.12479","volume":"28","author":"P Carta","year":"2015","unstructured":"Carta P, Zanazzi M, Minetti EE (2015) Unplanned pregnancies in kidney transplanted patients treated with everolimus: three case reports. Transpl Int 28(3):370\u2013372","journal-title":"Transpl Int"},{"issue":"6","key":"717_CR16","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/1756-185X.12996","volume":"20","author":"P Galappatthy","year":"2017","unstructured":"Galappatthy P, Jayasinghe JDD, Paththinige SC, Sheriff RMH, Wijayaratne LS (2017) Pregnancy outcomes and contraceptive use in patients with systemic lupus Erythematosus, rheumatoid arthritis and women without a chronic illness: a comparative study. Int J Rheum Dis. 20(6):746\u2013754","journal-title":"Int J Rheum Dis."},{"key":"717_CR17","doi-asserted-by":"crossref","unstructured":"Burgner A, Hladunewich MA (2019) Women\u2019s reproductive health for the nephrologist. Am J Kidney Dis. pii: S0272-6386(19)30737-1","DOI":"10.1053\/j.ajkd.2019.04.017"},{"issue":"3","key":"717_CR18","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/nrneph.2017.187","volume":"14","author":"KS Wiles","year":"2018","unstructured":"Wiles KS, Nelson-Piercy C, Bramham K (2018) Reproductive health and pregnancy in women with chronic kidney disease. Nat Rev Nephrol 14(3):165\u2013184","journal-title":"Nat Rev Nephrol"},{"issue":"4","key":"717_CR19","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.semnephrol.2017.05.004","volume":"37","author":"SB Ahmed","year":"2017","unstructured":"Ahmed SB, Vitek WS, Holley JL (2017) Fertility, contraception, and novel reproductive technologies in chronic kidney disease. Semin Nephrol 37(4):327\u2013336","journal-title":"Semin Nephrol"},{"issue":"3","key":"717_CR20","first-page":"252","volume":"14","author":"ME Yousif","year":"2016","unstructured":"Yousif ME, Bridson JM, Halawa A (2016) Contraception after kidney transplantation, from myth to reality: a comprehensive review of the current evidence. Exp Clin Transplant 14(3):252\u2013258","journal-title":"Exp Clin Transplant"},{"issue":"5","key":"717_CR21","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1053\/j.ackd.2013.06.005","volume":"20","author":"MA Josephson","year":"2013","unstructured":"Josephson MA, McKay DB (2013) Women and transplantation: fertility, sexuality, pregnancy, contraception. Adv Chronic Kidney Dis. 20(5):433\u2013440","journal-title":"Adv Chronic Kidney Dis."},{"issue":"1","key":"717_CR22","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.beem.2012.11.001","volume":"27","author":"P Gourdy","year":"2013","unstructured":"Gourdy P (2013) Diabetes and oral contraception. Best Pract Res Clin Endocrinol Metab 27(1):67\u201376","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"717_CR23","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jaut.2016.06.016","volume":"74","author":"MG Lazzaroni","year":"2016","unstructured":"Lazzaroni MG, Dall\u2019Ara F, Fredi M, Nalli C, Reggia R, Lojacono A, Ramazzotto F, Zatti S, Andreoli L, Tincani A (2016) A comprehensive review of the clinical approach to pregnancy and systemic lupus erythematosus. J Autoimmun 74:106\u2013117","journal-title":"J Autoimmun"},{"issue":"5","key":"717_CR24","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s40620-018-0499-x","volume":"31","author":"G Cabiddu","year":"2018","unstructured":"Cabiddu G, Spotti D, Gernone G, Santoro D, Moroni G, Gregorini G, Giacchino F, Attini R, Limardo M, Gammaro L, Todros T, Piccoli GB, Kidney and Pregnancy Study Group of the Italian Society of Nephrology (2018) A best-practice position statement on pregnancy after kidney transplantation: focusing on the unsolved questions. The Kidney and Pregnancy Study Group of the Italian Society of Nephrology. J Nephrol 31(5):665\u2013681","journal-title":"J Nephrol"},{"issue":"3","key":"717_CR25","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s40620-017-0390-1","volume":"30","author":"GB Piccoli","year":"2017","unstructured":"Piccoli GB, Cabiddu G, Castellino S, Gernone G, Santoro D, Moroni G, Spotti D, Giacchino F, Attini R, Limardo M, Maxia S, Fois A, Gammaro L, Todros T, Kidney and Pregnancy Study Group of Italian Society of Nephrology (2017) A best practice position statement on the role of the nephrologist in the prevention and follow-up of preeclampsia: the Italian study group on kidney and pregnancy. J Nephrol. 30(3):307\u2013317","journal-title":"J Nephrol."},{"issue":"3","key":"717_CR26","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s40620-016-0285-6","volume":"29","author":"G Cabiddu","year":"2016","unstructured":"Cabiddu G, Castellino S, Gernone G, Santoro D, Moroni G, Giannattasio M, Gregorini G, Giacchino F, Attini R, Loi V, Limardo M, Gammaro L, Todros T, Piccoli GB (2016) A best practice position statement on pregnancy in chronic kidney disease: the Italian Study Group on Kidney and Pregnancy. J Nephrol. 29(3):277\u2013303","journal-title":"J Nephrol."},{"issue":"3","key":"717_CR27","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s40620-015-0191-3","volume":"28","author":"G Cabiddu","year":"2015","unstructured":"Cabiddu G, Castellino S, Gernone G, Santoro D, Giacchino F, Credendino O, Daidone G, Gregorini G, Moroni G, Attini R, Minelli F, Manisco G, Todros T, Piccoli GB, Kidney and Pregnancy Study Group of Italian Society of Nephrology (2015) Best practices on pregnancy on dialysis: the Italian Study Group on Kidney and Pregnancy. J Nephrol. 28(3):279\u2013288","journal-title":"J Nephrol."},{"key":"717_CR28","unstructured":"https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/181468\/9789241549158_eng.pdf?sequence=9. Accessed 20 Nov 2019"},{"key":"717_CR29","first-page":"747","volume-title":"Contraceptive technology","author":"J Trussell","year":"2007","unstructured":"Trussell J (2007) Contraceptive efficacy. In: Hatcher RA, Trussell J, Nelson AL, Cates W, Stewart F, Kowal D (eds) Contraceptive technology, 19th edn. Ardent Media, New York, pp 747\u2013826","edition":"19"},{"key":"717_CR30","unstructured":"https:\/\/www.prb.org\/2019-family-planning-data-sheet-highlights-family-planning-method-use-around-the-world\/. Accessed 20 Nov 2019"},{"key":"717_CR31","unstructured":"https:\/\/www.ema.europa.eu\/en\/find-medicine\/human-medicines\/referrals\/combined-hormonal-contraceptives. Accessed 20 Nov 2019"},{"key":"717_CR32","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.thromres.2018.03.005","volume":"165","author":"C Oedingen","year":"2018","unstructured":"Oedingen C, Scholz S, Razum O (2018) Systematic review and meta-analysis of the association of combined oral contraceptives on the risk of venous thromboembolism: the role of the progestogen type and oestrogen dose. Thromb Res 165:68\u201378","journal-title":"Thromb Res"},{"issue":"339","key":"717_CR33","doi-asserted-by":"crossref","first-page":"b2921","DOI":"10.1136\/bmj.b2921","volume":"13","author":"Vlieg A Van Hylckama","year":"2009","unstructured":"Van Hylckama Vlieg A, Helmerhorst FM, Vandenbroucke JP, Doggen CJ, Rosendaal FR (2009) The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study. BMJ 13(339):b2921","journal-title":"BMJ"},{"issue":"2","key":"717_CR34","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.contraception.2016.10.005","volume":"95","author":"NK Tepper","year":"2017","unstructured":"Tepper NK, Dragoman MV, Gaffield ME, Curtis KM (2017) Nonoral combined hormonal contraceptives and thromboembolism: a systematic review. Contraception 95(2):130\u2013139","journal-title":"Contraception"},{"issue":"342","key":"717_CR35","doi-asserted-by":"crossref","first-page":"d2151","DOI":"10.1136\/bmj.d2151","volume":"21","author":"SS Jick","year":"2011","unstructured":"Jick SS, Hernandez RK (2011) Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case-control study using United States claims data. BMJ 21(342):d2151","journal-title":"BMJ"},{"issue":"342","key":"717_CR36","doi-asserted-by":"publisher","first-page":"d3349","DOI":"10.1136\/bmj.d3349","volume":"31","author":"A Szarewski","year":"2011","unstructured":"Szarewski A, Mansour D (2011) Study subject to unmeasured confounders and biases. BMJ 31(342):d3349. https:\/\/doi.org\/10.1136\/bmj.d3349","journal-title":"BMJ"},{"key":"717_CR37","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1161\/01.CIR.94.3.483","volume":"94","author":"L Chasan-Taber","year":"1996","unstructured":"Chasan-Taber L, Willett WC, Manson JE et al (1996) Prospective study of oral contraceptives and hypertension among women in the United States. Circulation. 94:483\u2013489","journal-title":"Circulation."},{"issue":"10","key":"717_CR38","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1111\/jch.13042","volume":"19","author":"H Liu","year":"2017","unstructured":"Liu H, Yao J, Wang W, Zhang D (2017) Association between duration of oral contraceptive use and risk of hypertension: a meta-analysis. J Clin Hypertens (Greenwich). 19(10):1032\u20131041. https:\/\/doi.org\/10.1111\/jch.13042(Epub 2017 Jun 13)","journal-title":"J Clin Hypertens (Greenwich)."},{"issue":"5","key":"717_CR39","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1053\/j.ackd.2013.07.002","volume":"20","author":"P August","year":"2013","unstructured":"August P (2013) Hypertension in women. Adv Chronic Kidney Dis. 20(5):396\u2013401. https:\/\/doi.org\/10.1053\/j.ackd.2013.07.002","journal-title":"Adv Chronic Kidney Dis."},{"issue":"2","key":"717_CR40","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1365-2125.2006.02747.x","volume":"63","author":"J Atthobari","year":"2007","unstructured":"Atthobari J, Gansevoort RT, Visser ST, de Jong PE, de Jong van den Berg LT, PREVEND Study Group (2007) The impact of hormonal contraceptives on blood pressure, urinary albumin excretion and glomerular filtration rate. Br J Clin Pharmacol. 63(2):224\u2013231","journal-title":"Br J Clin Pharmacol."},{"key":"717_CR41","first-page":"780","volume":"15","author":"SB Ahmed","year":"2004","unstructured":"Ahmed SB, Kang AK, Burns KD et al (2004) Effects of oral contraceptive use on the renal and systemic vascular response to angiotensin II infusion. JAmSocNephrol. 15:780\u2013786","journal-title":"JAmSocNephrol."},{"key":"717_CR42","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.2337\/diacare.28.8.1988","volume":"28","author":"B Ahmed","year":"2005","unstructured":"Ahmed B, Hovind P, Parving HH et al (2005) Oral contraceptives, angiotensin-dependent renal vasoconstriction, and risk of diabetic nephropathy. Diabetes Care. 28:1988\u20131994","journal-title":"Diabetes Care."},{"key":"717_CR43","first-page":"2000","volume":"161","author":"TB Monster","year":"2001","unstructured":"Monster TB, Janssen WM, and Prevention of Renal and Vascular End Stage Disease Study Group (2001) Oral contraceptive use and hormone replacement therapy are associated with microalbuminuria. ArchIntern Med. 161:2000\u20132005","journal-title":"ArchIntern Med."},{"issue":"3","key":"717_CR44","doi-asserted-by":"crossref","first-page":"R807","DOI":"10.1152\/ajpregu.2001.280.3.R807","volume":"280","author":"AK Kang","year":"2001","unstructured":"Kang AK, Duncan JA, Cattran DC, Floras JS, Lai V, Scholey JW, Miller JA (2001) Effect of oral contraceptives on the renin angiotensin system and renal function. Am J Physiol Regul Integr Comp Physiol 280(3):R807\u2013R813","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"1","key":"717_CR45","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1161\/01.HYP.33.1.90","volume":"33","author":"J Ribstein","year":"1999","unstructured":"Ribstein J, Halimi JM, du Cailar G, Mimran A (1999) Renal characteristics and effect of angiotensin suppression in oral contraceptive users. Hypertension 33(1):90\u201395","journal-title":"Hypertension"},{"issue":"8","key":"717_CR46","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1177\/0091270006289973","volume":"46","author":"R Sch\u00fcrmann","year":"2006","unstructured":"Sch\u00fcrmann R, Blode H, Benda N, Cronin M, K\u00fcfner A (2006) Effect of drospirenone on serum potassium and drospirenone pharmacokinetics in women with normal or impaired renal function. J Clin Pharmacol 46(8):867\u2013875","journal-title":"J Clin Pharmacol"},{"issue":"5","key":"717_CR47","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1111\/jog.13291","volume":"43","author":"Y Peng","year":"2017","unstructured":"Peng Y, Wang X, Feng H, Yan G (2017) Is oral contraceptive use associated with an increased risk of cervical cancer? An evidence-based meta-analysis. J Obstet Gynaecol Res. 43(5):913\u2013922","journal-title":"J Obstet Gynaecol Res."},{"key":"717_CR48","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2188\/jea.JE20150047","volume":"26","author":"HY Oh","year":"2016","unstructured":"Oh HY, Kim MK, Seo S, Lee J (2016) Association of combined tobacco smoking and oral contraceptive use with cervical intraepithelial neoplasia 2 or 3 in Korean women. J Epidemiol 26:22\u201329","journal-title":"J Epidemiol"},{"key":"717_CR49","doi-asserted-by":"crossref","first-page":"e1001182","DOI":"10.1371\/journal.pmed.1001182","volume":"9","author":"M Urban","year":"2012","unstructured":"Urban M, Banks E, Egger S et al (2012) Injectable and oral contraceptive use and cancers of the breast, cervix, ovary, and endometrium in black South African women: case\u2013control study. PLoS Med 9:e1001182","journal-title":"PLoS Med"},{"key":"717_CR50","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1743-7563.2008.00159.x","volume":"4","author":"M Nojomi","year":"2008","unstructured":"Nojomi M, Modaresgilani M, Mozafari N, Erfany A (2008) Cervical cancer and duration of using hormonal contraceptives. Asia Pac J Clin Oncol 4:107\u2013112","journal-title":"Asia Pac J Clin Oncol"},{"key":"717_CR51","first-page":"7","volume":"91","author":"N Vanakankovit","year":"2008","unstructured":"Vanakankovit N, Taneepanichskul S (2008) Effect of oral contraceptives on risk of cervical cancer. J Med Assoc Thai 91:7\u201312","journal-title":"J Med Assoc Thai"},{"key":"717_CR52","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1038\/sj.bjc.6601296","volume":"89","author":"J Green","year":"2003","unstructured":"Green J, Berrington DGA, Sweetland S et al (2003) Risk factors for adenocarcinoma and squamous cell carcinoma of the cervix in women aged 20\u201344 years: The UK National Case-Control Study of Cervical Cancer. Br J Cancer 89:2078\u20132086","journal-title":"Br J Cancer"},{"key":"717_CR53","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1023\/A:1024910808307","volume":"14","author":"S Shapiro","year":"2003","unstructured":"Shapiro S, Rosenberg L, Hoffman M et al (2003) Risk of invasive cancer of the cervix in relation to the use of injectable progestogen contraceptives and combined oestrogen\/progestogen oral contraceptives (South Africa). Cancer Causes Control 14:485\u2013495","journal-title":"Cancer Causes Control"},{"key":"717_CR54","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0140-6736(02)09578-8","volume":"360","author":"A Berrington","year":"2002","unstructured":"Berrington A, Jha P, Peto J, Green J, Hermon C (2002) Oral contraceptives and cervical cancer. Lancet 360:410","journal-title":"Lancet"},{"key":"717_CR55","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0140-6736(03)12949-2","volume":"361","author":"JS Smith","year":"2003","unstructured":"Smith JS, Green J, Berrington DGA et al (2003) Cervical cancer and use of hormonal contraceptives: a systematic review. Lancet 361:1159\u20131167","journal-title":"Lancet"},{"key":"717_CR56","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1158\/1055-9965.EPI-13-0298","volume":"22","author":"JM Gierisch","year":"2013","unstructured":"Gierisch JM, Coeytaux RR, Urrutia RP et al (2013) Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review. Cancer Epidemiol Biomark Prev 22:1931\u20131943","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"12","key":"717_CR57","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1016\/j.ejca.2010.04.018","volume":"46","author":"S Iodice","year":"2010","unstructured":"Iodice S, Barile M, Rotmensz N, Feroce I, Bonanni B, Radice P, Bernard L, Maisonneuve P, Gandini S (2010) Oral contraceptive use and breast or ovarian cancer risk in BRCA1\/2 carriers: a meta-analysis. Eur J Cancer 46(12):2275\u20132284","journal-title":"Eur J Cancer"},{"issue":"4","key":"717_CR58","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1158\/1055-9965.EPI-08-1005","volume":"18","author":"JM Dolle","year":"2009","unstructured":"Dolle JM, Daling JR, White E et al (2009) Risk factors for triple-negative breast cancer in women under the age of 45 years. Cancer Epidemiol Biomark Prev 18(4):1157\u20131166","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"3","key":"717_CR59","doi-asserted-by":"crossref","first-page":"156","DOI":"10.4103\/0970-258X.255759","volume":"31","author":"I Vanidassane","year":"2018","unstructured":"Vanidassane I, Gogia A, Kumar L (2018) Contemporary hormonal contraceptives and breast cancer risk: what do we learn? Natl Med J India. 31(3):156\u2013157","journal-title":"Natl Med J India."},{"key":"717_CR60","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.critrevonc.2019.03.001","volume":"137","author":"L Del Pup","year":"2019","unstructured":"Del Pup L, Codacci-Pisanelli G, Peccatori F (2019) Breast cancer risk of hormonal contraception: counselling considering new evidence. Crit Rev Oncol Hematol 137:123\u2013130","journal-title":"Crit Rev Oncol Hematol"},{"issue":"6","key":"717_CR61","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1080\/09513590.2019.1576610","volume":"35","author":"P Barriga","year":"2019","unstructured":"Barriga P, Vanhauwaert P, Porcile A (2019) Hormonal contraception and risk of breast cancer: a critical look. Gynecol Endocrinol 35(6):460\u2013462","journal-title":"Gynecol Endocrinol"},{"issue":"5","key":"717_CR62","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.jogoh.2019.02.006","volume":"48","author":"D Serfaty","year":"2019","unstructured":"Serfaty D (2019) Update on the contraceptive contraindications. J Gynecol Obstet Hum Reprod. 48(5):297\u2013307. https:\/\/doi.org\/10.1016\/j.jogoh.2019.02.006 (Epub 2019 Feb 20)","journal-title":"J Gynecol Obstet Hum Reprod."},{"issue":"1","key":"717_CR63","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1080\/13697137.2018.1540566","volume":"22","author":"J Bitzer","year":"2019","unstructured":"Bitzer J (2019) Overview of perimenopausal contraception. Climacteric 22(1):44\u201350","journal-title":"Climacteric"},{"issue":"4","key":"717_CR64","first-page":"258","volume":"62","author":"T Nagyk\u00e1lnai","year":"2018","unstructured":"Nagyk\u00e1lnai T, Landherr L (2018) Oral contraception and the risk of breast cancer. Review of the literature. Magy Onkol. 62(4):258\u2013263","journal-title":"Magy Onkol."},{"issue":"12","key":"717_CR65","first-page":"883","volume":"46","author":"L Amat","year":"2018","unstructured":"Amat L, Bulach A, Leclercq M, Mesrine S, Scheffler F, Sperandeo D, Scheffler M (2018) Additional non-contraceptive effects of contraception: CNGOF Contraception Guidelines. Gynecol Obstet Fertil Senol. 46(12):883\u2013888","journal-title":"Gynecol Obstet Fertil Senol."},{"issue":"12","key":"717_CR66","first-page":"834","volume":"46","author":"D Pragout","year":"2018","unstructured":"Pragout D, Laurence V, Baffet H, Raccah-Tebeka B, Rousset-Jablonski C (2018) Contraception and cancer: CNGOF contraception guidelines. Gynecol Obstet Fertil Senol 46(12):834\u2013844","journal-title":"Gynecol Obstet Fertil Senol"},{"issue":"5\u20136","key":"717_CR67","first-page":"369","volume":"42","author":"P Pasanisi","year":"2018","unstructured":"Pasanisi P, Bruno E (2018) Breast cancer in BRCA mutations carriers: is it time forn a \u201clifestyle\u201d primary prevention? Epidemiol Prev 42(5\u20136):369\u2013371","journal-title":"Epidemiol Prev"},{"issue":"6","key":"717_CR68","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/GCO.0000000000000493","volume":"30","author":"R Schneyer","year":"2018","unstructured":"Schneyer R, Lerma K (2018) Health outcomes associated with use of hormonal contraception: breast cancer. Curr Opin Obstet Gynecol 30(6):414\u2013418","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"3","key":"717_CR69","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.contraception.2018.05.002","volume":"98","author":"CL Westhoff","year":"2018","unstructured":"Westhoff CL, Pike MC (2018) Hormonal contraception and breast cancer. Contraception 98(3):171\u2013173","journal-title":"Contraception"},{"key":"717_CR70","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0140-6736(73)92594-4","volume":"2","author":"JK Baum","year":"1973","unstructured":"Baum JK, Bookstein JJ, Holtz F et al (1973) Possible association between benign hepatomas and oral contraceptives. Lancet 2:926\u2013929","journal-title":"Lancet"},{"key":"717_CR71","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1196\/annals.1386.044","volume":"1089","author":"L Giannitrapani","year":"2006","unstructured":"Giannitrapani L, Soresi M, Spada E et al (2006) Sex hormones and risk of liver tumor. Ann N Y Acad Sci 1089:228\u2013236","journal-title":"Ann N Y Acad Sci"},{"key":"717_CR72","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0016-5085(19)32205-X","volume":"73","author":"G Klatskin","year":"1977","unstructured":"Klatskin G (1977) Hepatic tumors: possible relationship to use of oral contraceptives. Gastroenterology 73:386\u2013394","journal-title":"Gastroenterology"},{"key":"717_CR73","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/j.0001-6349.2004.00551.x","volume":"83","author":"O Gemer","year":"2004","unstructured":"Gemer O, Moscovici O, Ben-Horin CL et al (2004) Oral contraceptives and liver hemangioma: a case-control study. Acta Obstet. Gynecol. Scand. 83:1199\u20131201","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"717_CR74","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1136\/gut.2003.038646","volume":"53","author":"V Glinkova","year":"2004","unstructured":"Glinkova V, Shevah O, Boaz M et al (2004) Hepatic haemangiomas: possible association with female sex hormones. Gut 53:1352\u20131355","journal-title":"Gut"},{"key":"717_CR75","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0140-6736(08)60167-1","volume":"371","author":"V Beral","year":"2008","unstructured":"Beral V, Doll R, Hermon C, Peto R, Reeves G (2008) Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls. Lancet 371:303\u2013314","journal-title":"Lancet"},{"issue":"2","key":"717_CR76","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.3802\/jgo.2019.30.e18","volume":"30","author":"M Kim","year":"2019","unstructured":"Kim M, Suh DH, Lee KH, Eom KY, Toftdahl NG, Mirza MR, Kim JW (2019) Major clinical research advances in gynecologic cancer in 2018. J Gynecol Oncol. 30(2):e18","journal-title":"J Gynecol Oncol."},{"issue":"1","key":"717_CR77","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/CEJ.0000000000000217","volume":"26","author":"C La Vecchia","year":"2017","unstructured":"La Vecchia C (2017) Ovarian cancer: epidemiology and risk factors. Eur J Cancer Prev. 26(1):55\u201362 (Review)","journal-title":"Eur J Cancer Prev."},{"issue":"362","key":"717_CR78","doi-asserted-by":"crossref","first-page":"k3609","DOI":"10.1136\/bmj.k3609","volume":"26","author":"L Iversen","year":"2018","unstructured":"Iversen L, Fielding S, Lidegaard \u00d8, M\u00f8rch LS, Skovlund CW, Hannaford PC (2018) Association between contemporary hormonal contraception and ovarian cancer in women of reproductive age in Denmark: prospective, nationwide cohort study. BMJ 26(362):k3609","journal-title":"BMJ"},{"issue":"5","key":"717_CR79","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s10552-016-0848-9","volume":"28","author":"A Koushik","year":"2017","unstructured":"Koushik A, Grundy A, Abrahamowicz M, Arseneau J, Gilbert L, Gotlieb WH, Lacaille J, Mes-Masson AM, Parent M\u00c9, Provencher DM, Richardson L, Siemiatycki J (2017) Hormonal and reproductive factors and the risk of ovarian cancer. Cancer Causes Control 28(5):393\u2013403","journal-title":"Cancer Causes Control"},{"key":"717_CR80","first-page":"CD003552","volume":"4","author":"LM Lopez","year":"2013","unstructured":"Lopez LM, Grimes DA, Gallo MF, Stockton LL, Schulz KF (2013) Skin patch and vaginal ring versus combined oral contraceptives for contraception. Cochrane Database Syst Rev. 4:CD003552","journal-title":"Cochrane Database Syst Rev."},{"issue":"4","key":"717_CR81","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.transproceed.2010.03.132","volume":"42","author":"DM Paternoster","year":"2010","unstructured":"Paternoster DM, Riboni F, Bertolino M, Garofalo G, Lazzarich E, Surico N, Stratta P (2010) The contraceptive vaginal ring in women with renal and liver transplantation: analysis of preliminary results. Transplant Proc. 42(4):1162\u20131165","journal-title":"Transplant Proc."},{"key":"717_CR82","first-page":"165","volume":"19","author":"J Saudi","year":"2008","unstructured":"Saudi J (2008) Pregnancy and contraceptive issues in renal transplant recipients. Kidney Dis Transpl 19:165","journal-title":"Kidney Dis Transpl"},{"key":"717_CR83","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1016\/j.transproceed.2007.09.014","volume":"39","author":"B Pietrzak","year":"2007","unstructured":"Pietrzak B, Bobrowska K, Jabiry-Zieniewicz Z et al (2007) Oral and transdermal hormonal contraception in women after kidney transplantation. Transplant Proc 39:2759","journal-title":"Transplant Proc"},{"issue":"4","key":"717_CR84","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.contraception.2013.03.004","volume":"88","author":"Z Vickery","year":"2013","unstructured":"Vickery Z, Madden T, Zhao Q, Secura GM, Allsworth JE, Peipert JF (2013) Weight change at 12\u00a0months in users of three progestin-only contraceptive methods. Contraception. 88(4):503\u2013508","journal-title":"Contraception."},{"key":"717_CR85","first-page":"CD008815","volume":"8","author":"LM Lopez","year":"2016","unstructured":"Lopez LM, Ramesh S, Chen M, Edelman A, Otterness C, Trussell J, Helmerhorst FM (2016) Progestin-only contraceptives: effects on weight. Cochrane Database Syst Rev. 8:CD008815","journal-title":"Cochrane Database Syst Rev."},{"issue":"3","key":"717_CR86","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/AOG.0000000000001289","volume":"127","author":"MF Gallo","year":"2016","unstructured":"Gallo MF, Legardy-Williams J, Hylton-Kong T, Rattray C, Kourtis AP, Jamieson DJ, Steiner MJ (2016) Association of progestin contraceptive implant and weight gain. Obstet Gynecol 127(3):573\u2013576","journal-title":"Obstet Gynecol"},{"issue":"9","key":"717_CR87","first-page":"715","volume":"89","author":"JR Yancey","year":"2014","unstructured":"Yancey JR, Raleigh M (2014) Progestin-only contraceptives: effects on weight. Am Fam Physician 89(9):715\u2013716","journal-title":"Am Fam Physician"},{"issue":"4","key":"717_CR88","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.contraception.2016.12.006","volume":"95","author":"PN Silva Dos Santos","year":"2017","unstructured":"Silva Dos Santos PN, Madden T, Omvig K, Peipert JF (2017) Changes in body composition in women using long-acting reversible contraception. Contraception. 95(4):382\u2013389","journal-title":"Contraception."},{"issue":"24","key":"717_CR89","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1056\/NEJMoa050817","volume":"353","author":"J S\u00e1nchez-Guerrero","year":"2005","unstructured":"S\u00e1nchez-Guerrero J, Uribe AG, Jim\u00e9nez-Santana L, Mestanza-Peralta M, Lara-Reyes P, Seuc AH, Cravioto MD (2005) A trial of contraceptive methods in women with systemic lupus erythematosus. N Engl J Med 353(24):2539\u20132549","journal-title":"N Engl J Med"},{"key":"717_CR90","unstructured":"FSRH (RCOG) Clinical Guideline: Progestogen-only pill, 2019. https:\/\/www.fsrh.org\/standards-and-guidance\/documents\/cec-ceu-guidance-pop-mar-2015\/. Accessed 20 Nov 2019"},{"issue":"6","key":"717_CR91","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.contraception.2016.04.014","volume":"94","author":"NK Tepper","year":"2016","unstructured":"Tepper NK, Whiteman MK, Marchbanks PA, James AH, Curtis KM (2016) Progestin-only contraception and thromboembolism: a systematic review. Contraception 94(6):678\u2013700","journal-title":"Contraception"},{"issue":"2","key":"717_CR92","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/GRF.0000000000000356","volume":"61","author":"B Gray","year":"2018","unstructured":"Gray B, Floyd S, James AH (2018) Contraceptive management for women who are at high risk of thrombosis. Clin Obstet Gynecol 61(2):243\u2013249","journal-title":"Clin Obstet Gynecol"},{"issue":"6","key":"717_CR93","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.fertnstert.2016.08.039","volume":"106","author":"R Sitruk-Ware","year":"2016","unstructured":"Sitruk-Ware R (2016) Hormonal contraception and thrombosis. Fertil Steril 106(6):1289\u20131294","journal-title":"Fertil Steril"},{"issue":"345","key":"717_CR94","doi-asserted-by":"crossref","first-page":"e4944","DOI":"10.1136\/bmj.e4944","volume":"7","author":"S Mantha","year":"2012","unstructured":"Mantha S, Karp R, Raghavan V, Terrin N, Bauer KA, Zwicker JI (2012) Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis. BMJ 7(345):e4944","journal-title":"BMJ"},{"issue":"2","key":"717_CR95","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.rdc.2016.12.001","volume":"43","author":"LR Sammaritano","year":"2017","unstructured":"Sammaritano LR (2017) Contraception in patients with rheumatic disease. Rheum Dis Clin North Am 43(2):173\u2013188. https:\/\/doi.org\/10.1016\/j.rdc.2016.12.001","journal-title":"Rheum Dis Clin North Am"},{"issue":"4","key":"717_CR96","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jpag.2019.03.008","volume":"32","author":"ME Romano","year":"2019","unstructured":"Romano ME, Braun-Courville DK (2019) Assessing weight status in adolescent and young adult users of the etonogestrel contraceptive implant. J Pediatr Adolesc Gynecol 32(4):409\u2013414","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"717_CR97","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ejogrb.2016.04.025","volume":"202","author":"J Villas-Boas","year":"2016","unstructured":"Villas-Boas J, Vilodre LC, Malerba H, Pontremoli Salcedo M, Foresti Jim\u00e9nez M, El Beitune P (2016) Metabolic safety of the etonogestrel contraceptive implant in healthy women over a 3-year period. Eur J Obstet Gynecol Reprod Biol 202:51\u201354","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"11","key":"717_CR98","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1093\/humrep\/dev221","volume":"30","author":"L Bahamondes","year":"2015","unstructured":"Bahamondes L, Brache V, Meirik O, Ali M, Habib N, Landoulsi S, WHO Study Group on Contraceptive Implants for Women (2015) A 3-year multicentre randomized controlled trial of etonogestrel- and levonorgestrel-releasing contraceptive implants, with non-randomized matched copper-intrauterine device controls. Hum Reprod. 30(11):2527\u20132538","journal-title":"Hum Reprod."},{"issue":"6","key":"717_CR99","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1007\/s00404-015-3784-0","volume":"292","author":"W Modesto","year":"2015","unstructured":"Modesto W, Dal Ava N, Monteiro I, Bahamondes L (2015) Body composition and bone mineral density in users of the etonogestrel-releasing contraceptive implant. Arch Gynecol Obstet 292(6):1387\u20131391","journal-title":"Arch Gynecol Obstet"},{"issue":"2","key":"717_CR100","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jbspin.2008.09.014","volume":"76","author":"J Sarfati","year":"2009","unstructured":"Sarfati J, de Vernejoul MC (2009) Impact of combined and progestogen-only contraceptives on bone mineral density. Joint Bone Spine. 76(2):134\u2013138","journal-title":"Joint Bone Spine."},{"key":"717_CR101","first-page":"33","volume":"6","author":"LM Lopez","year":"2014","unstructured":"Lopez LM, Grimes DA, Schulz KF, Curtis KM, Chen M (2014) Steroidal contraceptives: effect on bone fractures in women. Cochrane Database Syst Rev. 6:33","journal-title":"Cochrane Database Syst Rev."},{"issue":"3","key":"717_CR102","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ijgo.2010.01.018","volume":"109","author":"S Pongsatha","year":"2010","unstructured":"Pongsatha S, Ekmahachai M, Suntornlimsiri N, Morakote N, Chaovisitsaree S (2010) Bone mineral density in women using the subdermal contraceptive implant Implanon for at least 2\u00a0years. Int J Gynaecol Obstet 109(3):223\u2013225","journal-title":"Int J Gynaecol Obstet"},{"issue":"3","key":"717_CR103","first-page":"CD005214","volume":"19","author":"B Draper","year":"2006","unstructured":"Draper B, Morroni C, Hoffman M, Smit J, Beksinska M, Hapgood J, van der Merwe L (2006) Depot medroxyprogesterone versus Norethisterone oenanthate for long-acting progestogenic contraception. Cochrane Systematic Rev 19(3):CD005214","journal-title":"Cochrane Systematic Rev"},{"issue":"6","key":"717_CR104","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1080\/09513590.2017.1416465","volume":"34","author":"M Neri","year":"2018","unstructured":"Neri M, Piras B, Paoletti AM, Vallerino V, Corda V, Ronchetti C, Taccori V, Pilloni M, Zedda P, Capobianco G, Dessole S, Melis GB, Mais V (2018) Long-acting reversible contraception (LARC) with the intrauterine system with levonorgestrel (6\u00a0mcg\/day): observational study on the acceptability, quality of life, and sexuality in Italian women. Gynecol Endocrinol 34(6):532\u2013535","journal-title":"Gynecol Endocrinol"},{"issue":"5","key":"717_CR105","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/13625187.2018.1526898","volume":"23","author":"T Foran","year":"2018","unstructured":"Foran T, Butcher BE, Kovacs G, Bateson D, O\u2019Connor V (2018) Safety of insertion of the copper IUD and LNG-IUS in nulliparous women: a systematic review. Eur J Contracept Reprod Health Care. 23(5):379\u2013386","journal-title":"Eur J Contracept Reprod Health Care."},{"issue":"3","key":"717_CR106","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/annrheumdis-2016-209770","volume":"76","author":"L Andreoli","year":"2017","unstructured":"Andreoli L, Bertsias GK, Agmon-Levin N, Brown S, Cervera R et al (2017) EULAR recommendations for women\u2019s health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and\/or antiphospholipid syndrome. Ann Rheum Dis 76(3):476\u2013485","journal-title":"Ann Rheum Dis"},{"key":"717_CR107","unstructured":"FSRH (RCOG) Clinical Guideline: Intrauterine Contraception 2019. https:\/\/www.fsrh.org\/standards-and-guidance\/documents\/ceuguidanceintrauterinecontraception\/. Accessed 20 Nov 2019"},{"issue":"15","key":"717_CR108","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s12884-015-0613-1","volume":"22","author":"C Li","year":"2015","unstructured":"Li C, Zhao WH, Zhu Q, Cao SJ, Ping H, Xi X, Qin GJ, Yan MX, Zhang D, Qiu J, Zhang J (2015) Risk factors for ectopic pregnancy: a multi-center case-control study. BMC Pregnancy Childbirth 22(15):187","journal-title":"BMC Pregnancy Childbirth"},{"issue":"7","key":"717_CR109","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1016\/j.fertnstert.2018.08.022","volume":"110","author":"AJ Gaskins","year":"2018","unstructured":"Gaskins AJ, Missmer SA, Rich-Edwards JW, Williams PL, Souter I, Chavarro JE (2018) Demographic, lifestyle, and reproductive risk factors for ectopic pregnancy. Fertil Steril 110(7):1328\u20131337. https:\/\/doi.org\/10.1016\/j.fertnstert.2018.08.022","journal-title":"Fertil Steril"},{"issue":"3","key":"717_CR110","first-page":"278","volume":"55","author":"B Escobar-Padilla","year":"2017","unstructured":"Escobar-Padilla B, Perez-L\u00f3pez CA, Mart\u00ednez-Puon H (2017) Risk factors and clinical features of ectopic pregnancy. Rev Med Inst Mex Seguro Soc. 55(3):278\u2013285","journal-title":"Rev Med Inst Mex Seguro Soc."},{"issue":"1","key":"717_CR111","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0010-7824(95)00120-Y","volume":"52","author":"X Xiong","year":"1995","unstructured":"Xiong X, Buekens P, Wollast E (1995) IUD use and the risk of ectopic pregnancy: a meta-analysis of case-control studies. Contraception. 52(1):23\u201334","journal-title":"Contraception."},{"issue":"6","key":"717_CR112","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.bpobgyn.2014.05.004","volume":"28","author":"E Stephen-Searle","year":"2014","unstructured":"Stephen-Searle E (2014) The intrauterine device and the intrauterine system. Best Pract Res Clin Obstet Gynaecol. 28(6):807\u2013824","journal-title":"Best Pract Res Clin Obstet Gynaecol."},{"issue":"6","key":"717_CR113","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.contraception.2016.08.011","volume":"95","author":"PA Lohr","year":"2017","unstructured":"Lohr PA, Lyus R, Prager S (2017) Use of intrauterine devices in nulliparous women. Contraception. 95(6):529\u2013537","journal-title":"Contraception."},{"issue":"1","key":"717_CR114","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3109\/13625187.2014.971454","volume":"20","author":"S Sonalkar","year":"2015","unstructured":"Sonalkar S, Kapp N (2015) Intrauterine device insertion in the postpartum period: a systematic review. Eur J Contracept Reprod Health Care 20(1):4\u201318","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"6","key":"717_CR115","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1097\/AOG.0b013e318273364c","volume":"120","author":"CB Sufrin","year":"2012","unstructured":"Sufrin CB, Postlethwaite D, Armstrong MA, Merchant M, Wendt JM, Steinauer JE (2012) Neisseria gonorrhea and Chlamydia trachomatis screening at intrauterine device insertion and pelvic inflammatory disease. Obstet Gynecol 120(6):1314\u20131321","journal-title":"Obstet Gynecol"},{"issue":"8796","key":"717_CR116","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/0140-6736(92)91904-M","volume":"339","author":"TM Farley","year":"1992","unstructured":"Farley TM, Rosenberg MJ, Rowe PJ, Chen JH, Meirik O (1992) Intrauterine devices and pelvic inflammatory disease: an international perspective. Lancet 339(8796):785\u2013788","journal-title":"Lancet"},{"key":"717_CR117","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00006250-199102000-00019","volume":"77","author":"J Toivonen","year":"1991","unstructured":"Toivonen J, Luukkainen T, Allonen H (1991) Protective effect of intrauterine release of levonorgestrel on pelvic infection: three years\u2019 experience of levonorgestrel- and copper-releasing intrauterine devices. Obstet Gynecol 77:261\u2013264","journal-title":"Obstet Gynecol"},{"key":"717_CR118","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0015-0282(16)56455-3","volume":"61","author":"I Sivin","year":"1994","unstructured":"Sivin I, Stern J (1994) Health during prolonged use of levonorgestrel 20\u00a0mg\/d and the Copper TCu 380Ag intrauterine contraceptive devices: a multicenter study. Fertil Steril 61:70\u201377","journal-title":"Fertil Steril"},{"issue":"1","key":"717_CR119","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0010-7824(87)90057-6","volume":"36","author":"BL Sheppard","year":"1987","unstructured":"Sheppard BL (1987) Endometrial morphological changes in IUD users: a review. Contraception. 36(1):1\u201310","journal-title":"Contraception."},{"issue":"2","key":"717_CR120","doi-asserted-by":"crossref","first-page":"144.e1","DOI":"10.1016\/j.ajog.2007.03.031","volume":"197","author":"EM Stringer","year":"2007","unstructured":"Stringer EM, Kaseba C, Levy J, Sinkala M, Goldenberg RL, Chi BH, Matongo I, Vermund SH, Mwanahamuntu M, Stringer JS (2007) A randomized trial of the intrauterine contraceptive device vs hormonal contraception in women who are infected with the human immunodeficiency virus. Am J Obstet Gynecol 197(2):144.e1\u2013144.e8","journal-title":"Am J Obstet Gynecol"},{"key":"717_CR121","unstructured":"Flamigni C, Pompili A \u2013 Contraccezione, L\u2019Asino d\u2019oro Ed, 2011, www.lasinodoroedizioni.it. Accessed 20 Nov 2019"},{"issue":"3","key":"717_CR122","first-page":"281","volume":"158","author":"SD Fihn","year":"1998","unstructured":"Fihn SD, Boyko EJ, Chen CL, Normand EH, Yarbro P, Scholes D (1998) Arch; Use of spermicide-coated condoms and other risk factors for urinary tract infection caused by Staphylococcus saprophyticus. Intern Med 158(3):281\u2013287","journal-title":"Intern Med"},{"key":"717_CR123","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1001\/jama.1985.03360020072027","volume":"254","author":"SD Fihn","year":"1985","unstructured":"Fihn SD, Latham RH, Roberts P, Running K, Stamm WE (1985) Association between diaphragm use and urinary tract infection. JAMA. 254:240\u2013245","journal-title":"JAMA."},{"key":"717_CR124","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.2105\/AJPH.75.11.1308","volume":"75","author":"B Foxman","year":"1985","unstructured":"Foxman B, Frerichs RR (1985) Epidemiology of urinary tract infection, I: diaphragm use and sexual intercourse. Am J Public Health. 75:1308\u20131313","journal-title":"Am J Public Health."},{"key":"717_CR125","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1479-828X.1986.tb01572.x","volume":"26","author":"BA Peddie","year":"1986","unstructured":"Peddie BA, Bishop V, Blake EE, Gorrie SI, Bailey RR, Edwards D (1986) Association between diaphragm use and asymptomatic bacteriuria. Aust N Z J Obstet Gynaecol. 26:225\u2013227","journal-title":"Aust N Z J Obstet Gynaecol."},{"key":"717_CR126","first-page":"7497","volume":"2","author":"R Percival-Smith","year":"1983","unstructured":"Percival-Smith R, Bartlett KH, Chow AW (1983) Vaginal colonization of Escherichia coli and its relation to contraceptive methods. Contraception. 2:7497","journal-title":"Contraception."},{"issue":"7","key":"717_CR127","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1056\/NEJM199608153350703","volume":"335","author":"TM Hooton","year":"1996","unstructured":"Hooton TM, Scholes D, Hughes JP, Winter C, Roberts PL, Stapleton AE, Stergachis A, Stamm WE (1996) A prospective study of risk factors for symptomatic urinary tract infection in young women. N Engl J Med 335(7):468\u2013474","journal-title":"N Engl J Med"},{"issue":"6","key":"717_CR128","first-page":"687","volume":"68","author":"S Mittal","year":"2016","unstructured":"Mittal S (2016) Emergency contraception: which is the best? Minerva Ginecol 68(6):687\u2013699 (Epub 2016 Apr 15)","journal-title":"Minerva Ginecol"},{"issue":"3","key":"717_CR129","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/AOG.0000000000001047","volume":"126","author":"Practice Bulletin No 152","year":"2015","unstructured":"Practice Bulletin No 152 (2015) Emergency contraception. Obstet Gynecol 126(3):e1\u2013e11","journal-title":"Obstet Gynecol"},{"issue":"6","key":"717_CR130","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.jogn.2017.09.004","volume":"46","author":"A Art","year":"2017","unstructured":"Art A (2017) Emergency Contraception. J Obstet Gynecol Neonatal Nurs. 46(6):886\u2013888 (Emergency Contraception. Nurs Womens Health. 2017 21(6):506\u2013508)","journal-title":"J Obstet Gynecol Neonatal Nurs."},{"issue":"6","key":"717_CR131","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/GCO.0000000000000320","volume":"28","author":"WK Fok","year":"2016","unstructured":"Fok WK, Blumenthal PD (2016) Update on emergency contraception. Curr Opin Obstet Gynecol 28(6):522\u2013529","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"10","key":"717_CR132","first-page":"722","volume":"46","author":"KI Black","year":"2017","unstructured":"Black KI, Hussainy SY (2017) Emergency contraception: oral and intrauterine options. Aust Fam Physician 46(10):722\u2013726","journal-title":"Aust Fam Physician"},{"key":"717_CR133","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/bmb\/ldr015","volume":"98","author":"JB Nie","year":"2011","unstructured":"Nie JB (2011) Non-medical sex-selective abortion in China: ethical and public policy issues in the context of 40 million missing females. Br Med Bull 98:7\u201320","journal-title":"Br Med Bull"},{"key":"717_CR134","first-page":"1","volume":"22","author":"N Diamond-Smith","year":"2019","unstructured":"Diamond-Smith N, Saikia N, Bishai D, Canudas-Romo V (2019) What has contributed to improvements in the child sex ratio in select districts of India? A decomposition of the sex ratio at birth and child mortality. J Biosoc Sci 22:1\u201310","journal-title":"J Biosoc Sci"},{"key":"717_CR135","unstructured":"https:\/\/reproductiverights.org\/worldabortionlaws?country. Accessed 20 Nov 2019"},{"issue":"6","key":"717_CR136","first-page":"1431","volume":"27","author":"MA Boim","year":"1994","unstructured":"Boim MA, Draibe SA, Ramos OL, Ajzen H, Ulmann A, Schor N (1994) Glomerular hemodynamics during abortion induced by RU 486 and sepsis in rats. Braz J Med Biol Res 27(6):1431\u20131444","journal-title":"Braz J Med Biol Res"},{"key":"717_CR137","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ijgo.2011.01.016","volume":"114","author":"S Mittal","year":"2011","unstructured":"Mittal S, Aggarwal P (2011) Medical abortion in women with impaired renal function. Int J Gynaecol Obstet 114:76\u201377","journal-title":"Int J Gynaecol Obstet"},{"key":"717_CR138","first-page":"CD003037","volume":"1","author":"L Say","year":"2005","unstructured":"Say L, Kulier R, G\u00fclmezoglu M, Campana A (2005) Medical versus surgical methods for first trimester termination of pregnancy. Cochrane Database Syst Rev. 1:CD003037","journal-title":"Cochrane Database Syst Rev."}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-020-00717-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40620-020-00717-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-020-00717-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:56:22Z","timestamp":1777564582000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/33\/6\/1343\/8328424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,12]]},"references-count":138,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["717"],"URL":"https:\/\/doi.org\/10.1007\/s40620-020-00717-0","relation":{},"ISSN":["1121-8428","1724-6059"],"issn-type":[{"value":"1121-8428","type":"print"},{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,12]]},"assertion":[{"value":"24 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This is a review paper, approved by all authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}